Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Safety and Efficacy of ThisCART19A Bridging Hematopoietic Stem Cell Transplantation in Patients With Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT05576181. IPD Sharing: NO. Countries: 0. Publications: 0.
Decitabine Plus R-CHOP in Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT02951728. IPD Sharing: NO. Countries: 1. Publications: 0.
Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To Treatment
ClinicalTrials.gov study NCT00845104. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study of Secondary Infusion of Relmacabtagene Autoleucel Injection for Relapsed or Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT05814848. IPD Sharing: NO. Countries: 0. Publications: 0.
The Predictability of CD19 Expression Across Primitive Cellular Fractions of Relapsed B-ALL on Outcomes of CD19-targeted CAR T-cells
ClinicalTrials.gov study NCT06993766. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Study of Anti-CD19/CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma
ClinicalTrials.gov study NCT03824964. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Ofatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas
ClinicalTrials.gov study NCT01263418. IPD Sharing: Not stated. Countries: 0. Publications: 0.
G-Pola-GemOx in Refractory/Relapsed Aggressive B-Cell Lymphoma
ClinicalTrials.gov study NCT07184788. IPD Sharing: NO. Countries: 0. Publications: 0.
Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT02215629. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study of Brexucabtagene Autoleucel (KTE-X19) for the Treatment of Individuals With Relapsed/Refractory B-Cell Malignancies
ClinicalTrials.gov study NCT04162756. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial Evaluating the Efficacy and Safety of Daratumumab in Subjects With Relapsed/Refractory B-cell or T-cell Precursor Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT03207542. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Single-Arm, Expanded Access Study of Zanubrutinib in Participants With B-cell Malignancies
ClinicalTrials.gov study NCT04052854. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of CXD101 in Combination With Pembrolizumab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT03873025. IPD Sharing: NO. Countries: 0. Publications: 0.
CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute Leukemia/Malignant Lymphoma
ClinicalTrials.gov study NCT07383233. IPD Sharing: Not stated. Countries: 0. Publications: 0.
G-Pola-ZLP in Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT06665217. IPD Sharing: NO. Countries: 0. Publications: 0.
Autologous TAC T Cells Targeting CD19 in R/R Large B-Cell Lymphoma
ClinicalTrials.gov study NCT03880279. IPD Sharing: NO. Countries: 0. Publications: 0.
Study of Anti-CD19 iCAR NK Cells in Relapsed and Refractory B Cell Lymphoma
ClinicalTrials.gov study NCT03824951. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Rituximab-HyperCVAD (R-HCVAD) Alternating With Rituximab-Methotrexate-Cytarabine- (R-MC) in Newly Diagnosed Patients With Diffuse Large B-Cell Lymphoma With MYC-Rearrangement.
ClinicalTrials.gov study NCT01854372. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study Assessing the Safety and Efficacy of ABT-263 in Subjects With B-cell Chronic Lymphocytic Leukemia (CLL) Who Have Failed at Least One Prior Fludarabine-containing Regimen
ClinicalTrials.gov study NCT00918450. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study Comparing GB241 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT03003039. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.